Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Biogen Inc. buy HC Wainwright

Start price
€211.60
14.02.24 / 50%
Target price
€303.42
14.02.25
Performance (%)
-7.70%
Price
€195.30
26.04.24
Summary
This prediction is currently active. With a performance of -7.70%, the BUY prediction by HC_Wainwright is trending in the wrong direction. This prediction currently runs until 14.02.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Biogen Inc. 7.014% 7.014%
iShares Core DAX® 2.594% -1.158%
iShares Nasdaq 100 3.553% -1.727%
iShares Nikkei 225® 0.687% -8.354%
iShares S&P 500 2.209% -0.942%

Comments by HC_Wainwright for this prediction

In the thread Biogen Inc. diskutieren
Prediction Buy
Perf. (%) -7.70%
Target price 303.420
Change
Ends at 14.02.25

Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $325.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat

Stopped prediction by HC_Wainwright for Biogen Inc.

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€189.80
25.04.24
€280.50
25.04.25
2.90%
26.04.24

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€243.00
26.07.23
€293.57
26.07.24
-19.63%
26.04.24

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€244.95
23.03.23
€298.45
23.03.24
-17.94%
24.03.24